Key statistics dashboard for Lifecore Biomedical, Inc. (LFCR). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
Stock Data
| Price | $4.16 |
| Market Cap | $156M |
| Beta | 0.88 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -3.78 |
| Price / Book | 9.71 |
| P/S | 1.27 |
| P/FCF | -86.83 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 29.68% |
| EBIT Margin | -10.98% |
| EBITDA Margin | -3.38% |
| Operating Margin | -2.12% |
| Net Margin | -30.40% |
Financial Health
| Current Ratio | 3.87 |
| Quick Ratio | 2.69 |
| Cash Ratio | 0.80 |
| Debt / Equity | 9.64 |
| Debt / Assets | 67.57% |
| Interest Coverage | -0.09 |
Per-Share Data
| Revenue per share | 3.26 |
| Book Value per share | 0.43 |
| Cash per share | 0.46 |
| FCF per share | -0.05 |
| Tangible Book Value per share | 0.06 |
| Dividend per share | 0.00 |
Related companies: ACB · ACHV · BIOA · CGC · CVRX · IMMP · OMI
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of LFCR: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks